Neurofeedback During Eating for Bulimia Nervosa

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorIcahn School of Medicine at Mount Sinai

About this trial

The purpose of this study is to examine the effects of noninvasive prefrontal cortex (PFC) neurofeedback during eating in women with bulimia nervosa (BN) using a wearable brain imaging device, functional near-infrared spectroscopy (fNIRS). The investigators will examine how this training may influence inhibitory control and BN symptoms.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Female

Aged 18 to 45 years

Meet diagnostic criteria for bulimia nervosa

Current body mass index greater than or equal to 18.5kg/m2 but under 30kg/m2

Disqualifiers

Ongoing medical treatment, major medical condition, or psychiatric disorder that may interfere with study variables or participation

Current psychotherapy focused primarily on eating disorder symptoms

Pregnancy or planned pregnancy, or lactation during the study period

Allergy to ingredients in the standardized meal or in the shake

Trial design

Design model

Parallel

Treatments tested in this trial

  • Real fNIRS Neurofeedback

    Other intervention

    Participants will be instructed to use real-time fNIRS neurofeedback to non-invasively regulate neural activation associated with symptoms in individuals with bulimia nervosa. During the training, participants will view images on a computer screen, listen to sounds, and consume a shake.

  • Sham-Control fNIRS Neurofeedback

    Other intervention

    Participants will be instructed to use sham real-time fNIRS neurofeedback to non-invasively regulate neural activation associated with symptoms in individuals with bulimia nervosa. During the training, participants will view images on a computer screen, listen to sounds, and consume a shake.

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: Real fNIRS Neurofeedback ArmExperimental treatment 1 intervention
Group B: Sham-Control fNIRS Neurofeedback ArmSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Functional near-infrared spectroscopy (fNIRS)-measured neural activation and connectivity

The investigators will evaluate changes in PFC neural activation and connectivity as a function of neurofeedback.

Time frame
approximately 1 hour
2

Go/no-go task performance

Participants will complete a go/no-go task 1 week before and 1 week after the neurofeedback session to measure inhibitory control. Participants behavioral performance on the go/no-go task will be determined by the percentage of incorrect responses made as they are prompted to react to different pictorial stimuli. Participants' percentages of error can range from 0% to 100%. A higher percentage indicates a lower behavioral performance on the task.

Time frame
2 weeks
3

Number of loss-of-control eating and purging episodes

Frequency of loss-of-control eating and purging episodes. Participants will self-report on how often loss-of-control eating and purging episodes occur using electronic daily diaries in the week before and the week after the neurofeedback session.

Time frame
2 weeks
4

Severity of loss-of-control eating scale

Severity of loss-of-control eating. Participants will rate the severity of their feelings of control over eating and purging episodes on a Likert-type scale from 0-10. Higher score indicates greater severity of loss of control.

Time frame
2 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.